Signaling Pathways - MARK1 - ErbB - IDH2 - Vacuolar-type ATPase
清除全部
-
B1543 Mubritinib (TAK 165)中文名: 木利替尼Target: ErbBSummary: HER2/ErbB2有效抑制剂 -
A8633 Concanamycin A1 Citation中文名: 卡那霉素ATarget: Vacuolar-type ATPaseSummary: V型（液泡）H +-ATP酶抑制剂 -
A8375 AZD8931 (Sapitinib)中文名: 沙普替尼Target: EGFR|ErbBSummary: ErbB抑制剂 -
A8319 Dacomitinib (PF299804, PF299)中文名: 达克替尼Target: ErbBSummary: HER抑制剂 -
A8218 Lapatinib2 Citation中文名: 拉帕替尼Target: ErbBSummary: EGFR/HER2抑制剂 -
A3635 MRT67307 HClTarget: TBK1|MARK1|NUAK1Summary: SIK/TBK-1/IKKe抑制剂 -
A3146 AGI-6780Target: IDH2Summary: IDH2/R140Q突变抑制剂 -
A4092 CUDC-1011 CitationTarget: Histone Deacetylases (HDACs)|EGFR|ErbBSummary: 多靶点HDAC抑制剂